# Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Pathfinder Cell Therapy, Inc.
- **Former names in filing history:** SyntheMed, Inc. (2005-03-24 to 2011-09-09); LIFE MEDICAL SCIENCES INC (1994-02-14 to 2005-04-27)
- **Classification:** Company
- **Industry (SIC):** 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000889428

## About

Pathfinder Cell Therapy, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000889428, and its reported industry is Orthopedic, Prosthetic & Surgical Appliances & Supplies. In 10-K filed on 2015-03-31, it reported annual revenue of USD 0; net income of USD -1,394,000; total assets of USD 106,000 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.4M (USD -1,394,000)
- **Total assets:** $106,000 (USD 106,000)
- **Cash and equivalents:** $26,000 (USD 26,000)
- **Operating cash flow:** -$963,000 (USD -963,000)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $54,000 (USD 54,000)
- **Net income:** -$1.7M (USD -1,705,000)
- **Total assets:** $155,000 (USD 155,000)
- **Cash and equivalents:** $44,000 (USD 44,000)
- **Operating cash flow:** -$1.6M (USD -1,601,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $114,000 (USD 114,000)
- **Net income:** -$2.2M (USD -2,156,000)
- **Total assets:** $356,000 (USD 356,000)
- **Cash and equivalents:** $9,000 (USD 9,000)
- **Operating cash flow:** -$2.0M (USD -2,024,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $73,000 (USD 73,000)
- **Net income:** -$11.3M (USD -11,270,000)
- **Total assets:** $644,000 (USD 644,000)
- **Cash and equivalents:** $196,000 (USD 196,000)
- **Operating cash flow:** -$2.3M (USD -2,330,000)

## Recent SEC filings

- Form 8-K — filed 2016-03-29 — period 2016-03-29 — CURRENT REPORT
- Form 8-K — filed 2015-12-04 — period 2015-12-02 — CURRENT REPORT
- Form 10-Q — filed 2015-11-13 — period 2015-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2015-11-04 — period 2015-11-03 — CURRENT REPORT
- Form 8-K — filed 2015-10-07 — period 2015-10-06 — CURRENT REPORT
- Form 8-K — filed 2015-09-01 — period 2015-08-28 — CURRENT REPORT
- Form 8-K — filed 2015-08-18 — period 2015-08-17 — CURRENT REPORT
- Form 10-Q — filed 2015-08-13 — period 2015-06-30 — QUARTERLY REPORT
- Form 8-K — filed 2015-07-20 — period 2015-07-16 — CURRENT REPORT
- Form 8-K — filed 2015-06-09 — period 2015-06-05 — CURRENT REPORT
- Form 10-Q — filed 2015-05-15 — period 2015-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2015-03-31 — period 2014-12-31 — ANNUAL REPORT

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/pathfinder-cell-therapy-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology